Companies will participate in a customized mentorship program and compete for $250K in Prizes on Oct. 13 in Carlsbad, Calif. LOS ANGELES — BioTools Innovator, the first accelerator focused on life science tools and diagnostics to advance cutting-edge research and improve human health, announced that 14 companies have been selected to participate in its annual […]

EMERYVILLE, Calif. — SLINGSHOT BIOSCIENCES, INC., the developers of synthetic cells, today announced they have extended their distribution channel through a new agreement with Chameleon Science. Chameleon Science is an innovative new company specializing in the development and distribution of emerging technologies in Life Sciences. The Chameleon team has over 25 years of experience in […]

MINNEAPOLIS — Bio-Techne Corporation (NASDAQ:TECH), today announced it has completed the acquisition of Namocell, Inc. The Namocell acquisition adds easy-to-use single cell sorting and dispensing platforms that are gentle to cells and preserve cell viability and integrity. Namocell’s instruments and consumables are critical technologies in various workflows in both biotherapeutics and diagnostics, including cell and […]

Collaboration pairs Cytiva’s leadership in supplying end-to-end manufacturing solutions with Bayer’s strong expertise in technology and process development for complex therapeutics Action demonstrates Cytiva and Bayer’s commitment to advancing and accelerating the development of cell and gene therapies and expanding their accessibility for patients Cytiva and Bayer are teaming up to develop the first modular […]

The OncoSignature® test developed based on Acrivon’s AP3 platform is a first-of-its-kind spatial signature assay to identify patients most likely to respond to ACR-368, an advanced Phase 2 targeted oncology agent for solid cancers The OncoSignature® test will run on Akoya’s PhenoImager™ Solution MARLBOROUGH, Mass. and WATERTOWN, Mass. — Akoya Biosciences, Inc., (Nasdaq: AKYA), The Spatial Biology Company®, […]

Edinburgh, UK – Cytomos, an Edinburgh-based life science company that has developed a proprietary new approach to analysing cells, has secured £1.6m funding to progress the development and qualification of its novel cell analysis platform, Cytomos Dielectric Spectroscopy (CDS). The fundraising round by Cytomos was led by existing investor Archangels with participation from Scottish Enterprise and Old College Capital. Cytomos […]

Scientists recognized for their outstanding contributions in automated cell culture technologies to support clonal selection and process development for biopharmaceuticals, vaccines, and cell and gene therapies GÖTTINGEN, Germany — Sartorius, a leading international partner of life science research and the biopharmaceutical industry, is pleased to announce that Richard Wales, Ph.D., and Neal Bargh were named the 2022 […]

Seminal presentation of first analytical validation data scheduled for june 30 Genomill, a precision diagnostics company focused on maximizing next generation sequencing (NGS) in liquid biopsies, announces today that Mike Doherty, the former Head of Product Development at Foundation Medicine, has been appointed to the company’s Board of Directors. In addition to the Board membership, Mike […]

Cambridge, UK – Abcam plc (“Abcam”, “Company”, “Group”) (AIM: ABC; Nasdaq: ABCM), a global leader in the supply of life science research tools, today announces the appointment of Tommy Thomas as Vice President of Investor Relations. Tommy, who will be based in our Waltham, MA office, has over 20 years’ experience in the life sciences sector, […]

EMERYVILLE, CA — SLINGSHOT BIOSCIENCES, INC., the makers of synthetic cells that bring consistent precision and accurate control to replace inconsistent blood and tissue controls for use in flow cytometry and other biotech markets, today announced they have extended their distribution channel through a new agreement with Almog Diagnostic, a private company established in 1987 […]